FDA Regulations and Auditing Practices for Software Suppliers at a Pharmaceutical Manufacturer

If you are not automatically redirected, follow this link:
http://asq.org/qic/display-item/?item=19719

Theisen; Timothy W.; Neill, Colin J.   (2004, ASQ)   The Pennsylvania State University, University Park, PA

A review of 17 quality audit reports performed between 1992 and 2003 by an international pharmaceutical company identifies three time frames of audit maturity based on government regulation enforcement patterns, supplier quality practices, and the customer's changing expectations. Increased government surveillance caused the pharmaceutical company to make greater contractual demands on its suppliers to establish and comply with quality management practices. The maturity eras described are proposed as a new dimension for audit maturity in the pharmaceutical industry.

Free Subscriptions

Pharma Manufacturing Digital Edition

Access the entire print issue on-line and be notified each month via e-mail when your new issue is ready for you. Subscribe Today.

pharmamanufacturing.com E-Newsletters

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.